Rat brain DNA transcript profile of halothane and isoflurane exposure

Pharmacogenetics and Genomics

Volumn 16, Issue 3, 2006, Pages 171-182

  Pan, Jonathan Z ^a   Wei, Huafeng ^a   Hecker, James G ^a   Tobias, John W ^a   Eckenhoff, Roderic G ^a   Eckenhoff, Maryellen Fazen ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anesthesia; CNS; DNA microarrays; Gene expression; Gene expression profiling; Microarray analysis; Regulation of gene expression; Volatile anesthetic

Indexed keywords

ANESTHETIC AGENT; BRAIN PROTEIN; HALOTHANE; ISOFLURANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; DNA TRANSCRIPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNAPSE VESICLE; TRANSCRIPTION REGULATION;

ANESTHETICS, INHALATION; ANIMALS; BRAIN; DNA; GENE EXPRESSION PROFILING; HALOTHANE; ISOFLURANE; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES; PHARMACOGENETICS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 33644591586     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Richards CD, Smaje JC. Anaesthetics depress the sensitivity of cortical neurones to L-glutamate. Br J Pharmacol 1976; 58:347-357.
2. Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors? Nature 1984; 310:599-601.
3. Segal IS, Vickery RG, Walton JK, Doze VA, Maze M. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology 1988; 69:818-823.
4. Anthony BL, Dennison RL, Aronstam RS. Disruption of muscarinic receptor-G protein coupling is a general property of liquid volatile anesthetics. Neurosci Lett 1989; 99:191-196.
5. Daigle I, Gilbert M, Boucher F. Halogenated general anesthetics in visual photoreceptor membranes as examined by static and dynamic properties of rhodopsin. Biochem Cell Biol 1993; 71:57-64.
6. El Maghrabi EA, Eckenhoff RG. Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology 1993; 78:750-756.
7. Slater SJ, Cox KJ, Lombardi JV, Ho C, Kelly MB, Rubin E, et al. Inhibition of protein kinase C by alcohols and anaesthetics. Nature 1993; 364:82-84.
8. Covarrubias M, Vyas TB, Escobar L, Wei A. Alcohols inhibit a cloned potassium channel at a discrete saturable site: insights into the molecular basis of general anesthesia. J Biol Chem 1995; 270:19408-19416.
9. Karon BS, Geddis LM, Kutchai H, Thomas DD. Anesthetics alter the physical and functional properties of the Ca-ATPase in cardiac sarcoplasmic reticulum. Biophys J 1995; 68:936-945.
10. Durieux ME. Muscarinic signaling in the central nervous system. Recent developments and anesthetic implications. Anesthesiology 1996; 84:173-189.
11. Hemmings HC Jr, Adamo AI. Activation of endogenous protein kinase C by halothane in synaptosomes. Anesthesiology 1996; 84:652-662.
12. Raines DE. Anesthetic and nonanesthetic halogenated volatile compounds have dissimilar activities on nicotinic acetylcholine receptor desensitization kinetics. Anesthesiology 1996; 84:663-671.
13. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology 1996; 84:1223-1233.
14. Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389:385-389.
15. Minami K, Wick MJ, Stern-Bach Y, Dildy-Mayfield JE, Brozowski SJ, Gonzales EL, et al. Sites of volatile anesthetic action on kainate (glutamate receptor 6) receptors. J Biol Chem 1998; 273:8248-8255.
16. Kaech S, Brinkhaus H, Matus A. Volatile anesthetics block actin-based motility in dendritic spines. Proc Natl Acad Sci USA 1999; 96:10433-10437.
17. Eckenhoff RG, Johansson JS. In: Yaksh TL, Lynch C, Zapol WM, Maze M, Biebuyck JF, Saidman LJ, editors. Anesthesia: biologic foundations. Philadelphia, Pennsylvania: Lippincott-Raven; 1997. pp. 19-32.
18. Eckenhoff MF, Eckenhoff RG. Quantitative autoradiography of halothane binding in rat brain. J Pharmacol Exp Ther 1998; 285:371-376.
19. Eckenhoff MF, Chan K, Eckenhoff RG. Multiple specific binding targets for inhaled anesthetics in the mammalian brain. J Pharmacol Exp Ther 2002; 300:172-179.
20. Hamaya Y, Takeda T, Dohi S, Nakashima S, Nozawa Y. The effects of pentobarbital, isoflurane, and propofol on immediate-early gene expression in the vital organs of the rat. Anesth Analg 2000; 90:1177-1183.
21. Marota JJ, Crosby G, Uhl GR. Selective effects of pentobarbital and halothane on c-fos and jun-B gene expression in rat brain. Anesthesiology 1992; 77:365-371.
22. Wei H, Kang B, Wei W, Liang G, Meng QC, Li Y, et al. Isoflurane and sevoflurane affect cell survival and BCL-2/BAX ratio differently. Brain Res 2005; 1037:139-147.
23. The Tumor Analysis Best Practices Working Group. Expression profiling-best practices for data generation and interpretation in clinical trials. Nat Rev Genet 2004; 5:229-237.
24. Ririe KM, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal Biochem 1997; 245:154-160.
25. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. The LightCycler (TM) a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 1997; 22:176-181.
26. Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, Raftogianis RB. Sulfotransferase molecular biology: cDNAs and genes. FASEB J 1997; 11:3-14.
27. Smith GP. The controls of eating: a shift from nutritional homeostasis to behavioral neuroscience. Nutrition 2000; 16:814-820.
28. Li JY, Lescure PA, Misek DE, Lai YM, Chai BX, Kuick R, et al. Food deprivation-induced expression of minoxidil sulfotransferase in the hypothalamus uncovered by microarray analysis. J Biol Chem 2002; 277:9069-9076.
29. Martin JL, Meinwald J, Radford P, Liu Z, Graf ML, Pohl LR. Stereoselective metabolism of halothane enantiomers to trifluoroacetylated liver proteins. Drug Metab Rev 1995; 27:179-189.
30. Minoda Y, Kharasch ED. Halothane-dependent lipid peroxidation in human liver microsomes is catalyzed by cytochrome P4502A6 (CYP2A6). Anesthesiology 2001; 95:509-514.
31. Eger EI. Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health Syst Pharm 2004; 61:S3-S10.
32. Marshall BE, Longnecker DE. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon R, Gilman AG, editors. The pharmacological basis of therapeutics. 9th edn. New York: McGraw-Hill Publisher; 1996. pp. 307-330.
33. Wise-Faberowski L, Aono M, Pearlstein RD, Warner DS. Apoptosis is not enhanced in primary mixed neuronal/glial cultures protected by isoflurane against N-methyl-D-aspartate excitotoxicity. Anesth Analg 2004; 99:1708-1714.
34. Okamoto M, Schoch S, Sudhof TC. EHSH1/intersectin, a protein that contains EH and SH3 domains and binds to dynamin and SNAP-25 - a protein connection between exocytosis and endocytosis? J Biol Chem 1999; 274:18446-18454.
35. van Swinderen B, Saifee O, Shebester L, Roberson R, Nonet ML, Crowder CM. A neomorphic syntaxin mutation blocks volatile-anesthetic action in Caenorhabditis elegans. Proc Natl Acad Sci USA 1999; 96:2479-2484.
36. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348:2110-2114.
37. Hawasli AH, Saifee O, Liu C, Nonet ML, Crowder CM. Resistance to volatile anesthetics by mutations enhancing excitatory neurotransmitter release in Caenorhabditis elegans. Genetics 2004; 168:831-843.
38. Hasegawa H, Negishi M, Ichikawa A. Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol Chem 1996; 271:1857-1860.
39. Ishizawa Y, Pidikiti R, Liebman PA, Eckenhoff RG. G protein-coupled receptors as direct targets of inhaled anesthetics. Mol Pharmacol 2002; 61:945-952.
40. Ishizawa Y, Peterlin Z, Kini AB, Eckenhoff RG, Firestein S. Selectivity of volatile anesthetic action in a homologous population of G protein coupled receptors. Anesthesiology 2004; 101:A823.
41. Erck C, Frank R, Wehland J. Tubulin-tyrosine ligase, a long-lasting enigma. Neurochem Res 2000; 25:5-10.
42. Arriza JL, Kavanaugh MP, Fairman WA, Wu YN, Murdoch GH, North RA, et al. Cloning and expression of a human neutral amino acid transporter with structural similarity to the glutamate transporter gene family. J Biol Chem 1993; 268:15329-15332.
43. Kanai Y, Smith CP, Hediger MA. The elusive transporters with a high affinity for glutamate. Trends Neurosci 1993; 16:365-370.
44. Palmer LK, Wolfe D, Keeley JL, Keil RL. Volatile anesthetics affect nutrient availability in yeast. Genetics 2002; 161:563-574.
45. Gotti C, Clementi F. Neuronal nicotinic receptors: from structure to pathology. Prog Neurobiol 2004; 74:363-396.
46. Sudweeks SN, Yakel JL. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 2000; 527:515-528.
47. Pearce RA. Volatile anaesthetic enhancement of paired-pulse depression investigated in the rat hippocampus in vitro. J Physiol 1996; 492:823-840.
48. Yamashita M, Mori T, Nagata K, Yeh JZ, Narahashi T. Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology 2005; 102:76-84.
49. Chiara DC, Dangott LJ, Eckenhoff RG, Cohen JB. Identification of nicotinic acetylcholine receptor amino acids photolabeled by the volatile anesthetic halothane. Biochemistry 2003; 42:13457-13467.
50. Jarvinen AK, Hautaniemi S, Edgren H, Auvinen P, Saarela J, Kallioniemi OP, et al. Are data from different gene expression microarray platforms comparable? Genomics 2004; 83:1164-1168.
51. Nadon R, Shoemaker J. Statistical issues with microarrays: processing and analysis. Trends Genet 2002; 18:265-271.
52. Smyth GK, Yang YH, Speed T. In: Brownstein MJ, Khodursky AB, editors. Functional genomics: methods and protocols. Totowa, New Jersey: Humana Press; 2003. pp. 111-136.
53. Slonim DK. From patterns to pathways: gene expression data analysis comes of age. Nat Genet 2002; 32 (Suppl):502-508.
54. Nau ME, Emerson LR, Martin RK, Kyle DE, Wirth DF, Vahey M. Technical assessment of the affymetrix yeast expression GeneChip YE6100 platform in a heterologous model of genes that confer resistance to antimalarial drugs in yeast. J Clin Microbiol 2000; 38:1901-1908.
55. Parmentier-Batteur S, Jin K, Xie L, Mao XO, Greenberg DA. DNA microarray analysis of cannabinoid signaling in mouse brain in vivo. Mol Pharmacol 2002; 62:828-835.
56. Thibault C, Lai C, Wilke N, Duong B, Olive MF, Rahman S, et al. Expression profiling of neural cells reveals specific patterns of ethanol-responsive gene expression. Mol Pharmacol 2000; 58:1593-1600.
57. Sergeev P, da Silva R, Lucchinetti E, Zaugg K, Pasch T, Schaub MC, et al. Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 2004; 100:474-488.
58. Wigle DA, Tsao M, Jurisica I. Making sense of lung-cancer gene expression profiles. Genome Biol 2004; 5:309-311.
59. Futterer CD, Maurer MH, Schmitt A, Feldmann RE, Kuschinsky W, Waschke KF. Alterations in rat brain proteins after desflurane anesthesia. Anesthesiology 2004; 100:302-308.